Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis

Completed · Phase 3

Conditions studied: Psoriasis

In brief

The primary objectives of this study are to evaluate the safety \& efficacy of consecutive treatments of Clobex® Spray and Silkis® Ointment in the management of plaque psoriasis.

Key facts

Study ID

NCT00658788

Run by

Galderma R&D

People needed

305

Starts

2008-03-01

Expected to finish

2009-01-01

Last updated by the study team

2022-08-23

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of moderate to severe plaque psoriasis, defined as 3% - 20% treatable body surface area
• Overall Disease Severity of at least 3 (moderate)

You may not qualify if…

• Surface area involvement too large (>20% BSA)
• Psoriasis involving only the scalp, groin, axillae, and/or other intertriginous areas

Where it is running

• Therapeutics Clinical Research — San Diego, California, United States
• MedaPhase, Inc. — Newnan, Georgia, United States
• Gwinnett Clinical Research Center, Inc — Snellville, Georgia, United States
• Hudson Dermatology — Evansville, Indiana, United States
• Mount Sinai Department of Dermatology — New York, New York, United States
• Northeastern Ohio Universities College of Medicine — Warren, Ohio, United States
• Central Sooner Research — Norman, Oklahoma, United States
• J&J Studies, Inc — College Station, Texas, United States
• Suzanne Bruce and Associates, PA — Houston, Texas, United States
• Virginia Clinical Research, Inc — Norfolk, Virginia, United States
• Dermatology Associates of Seattle, PLLC — Seattle, Washington, United States
• Madison Skin and Research, Inc — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.